Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
These symptoms usually improve as your body gets used to the medication
Early Response as Predictor Week 12 emerges as a critical assessment point in the data
Genetic variant of cyclooxygenase-2 in gastric cancer: More inflammation and susceptibility
Vomiting occurs in 5 to 12 percent of cases, more commonly at higher doses
Last Published 04.01.2026 Effective Date: 04.01.2026 This policy addresses the use of Givlaari (givosiran) for the treatment of acute hepatic porphyrias
US$ 27.32
US$ 28.85
US$ 24.94
US$ 20.23
US$ 25.02
US$ 27.18
US$ 24.19
US$ 20.23
US$ 21.75
